VELA ACQUISITION CORPORATION
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 29, 2010 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 125 Total Citation Count
- Oct 27, 1999 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7078398 Compositions and methods for treating or preventing convulsions or seizuresJul 23, 03Jul 18, 06[A61K]
6683072 Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsiaFeb 04, 03Jan 27, 04[A61K]
6649607 Compositions and methods for treating or preventing convulsions or seizuresNov 08, 01Nov 18, 03[A61K, C07C]
6080736 Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopamOct 27, 99Jun 27, 00[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7745431 Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereofExpiredDec 03, 03Jun 29, 10[A61K, A01N, C07D]
2007/0142,395 Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H-)-quinolone or salt thereofAbandonedDec 16, 05Jun 21, 07[A61K]
2007/0142,396 Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H-)-quinolone or salt thereofAbandonedDec 16, 05Jun 21, 07[A61K]
2007/0032,479 Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepinesAbandonedDec 03, 04Feb 08, 07[A61K]
2007/0021,412 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepineAbandonedJun 21, 06Jan 25, 07[A61K]
2006/0166,976 Compositions and methods for treating or preventing convulsions or seizuresAbandonedMar 24, 06Jul 27, 06[A61K]
7022700 Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepinesExpiredDec 03, 02Apr 04, 06[A61K]
2005/0288,277 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S)-2,3-benzodiazepineAbandonedJun 25, 04Dec 29, 05[A61K]
2005/0227,961 Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndromeAbandonedNov 30, 04Oct 13, 05[A61K]
6864251 Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepinesExpiredDec 03, 02Mar 08, 05[A61K]
2004/0254,173 Modulation of dopamine responses with substituted (S)-2,3-benzodiazepinesAbandonedJun 13, 03Dec 16, 04[A61K]
2004/0229,866 Method of lowering body temperature with (S)-2,3-benzodiazepinesAbandonedFeb 17, 04Nov 18, 04[A61K]
2004/0229,867 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (R) 2,3-benzodiazepineAbandonedMay 13, 04Nov 18, 04[A61K]
2004/0224,943 Method of lowering body temperature with (R) - 2,3-benzodiazepinesAbandonedApr 19, 04Nov 11, 04[A61K]
2004/0162,284 Method of lowering body temperature with (S) tofisopamAbandonedFeb 19, 03Aug 19, 04[A61K]
2004/0152,695 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-eth-yl-7,8-dimethoxy-5H-2,3-benzodiazepine and uses thereofAbandonedDec 03, 03Aug 05, 04[A61K]
2004/0138,209 Treatment of inflammatory disorders with 2,3- benzodiazepinesAbandonedDec 03, 03Jul 15, 04[A61K]
2004/0138,210 Method of increasing neutrophil production using 2,3-benzodiazepinesAbandonedDec 02, 03Jul 15, 04[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.